Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in Bosnia & Herzegovina
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in Bosnia & HerzegovinaStudy to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)
- Where
- Banja Luka, Sarajevo
- Age
- 18 years to 85 years
- People
- 126 worldwide
- Run by
- Foresee Pharmaceuticals Co., Ltd.
See details and how to joinNCT06475781